loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2018_125___rev_04 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Hameln rds

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 HAMELN RDS S.R.O. Modra SK (1)

    filter

    01 Remifentanil hydrochloride (1)

    filter

    01 Slovakia (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    HAMELN RDS S.R.O. Modra SK

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Slovakia
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Remifentanil hydrochloride

    PDF Supplier PDF
    URL Supplier Web Content
    CEP 2018-125 - Rev 04
    Valid
    Chemical
    2024-03-20
    2644
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for CEP 2018-125 - Rev 04 of Hameln Rds S.r.o. Modra Sk

    Looking for Certificates of Suitability (CEPs) for CEP 2018-125 - Rev 04 of Hameln Rds S.r.o. Modra Sk 1

    20

    Hameln Rds S.r.o. Modra Sk, based in Slovakia, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Focussed on development & production of pharmaceutical products, with emphasis on all analytical & galenical development steps.

    One of their significant offerings is Remifentanil hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2018-125 - Rev 04

    This Chemical Type CEP, issued on March 20, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2644 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY